WallStreetZenWallStreetZen

NASDAQ: AMGN
Amgen Inc Earnings & Revenue

AMGN past earnings growth

How has AMGN's earnings growth performed historically?
Company
28.15%
Industry
39.51%
Market
40.4%
AMGN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
AMGN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
AMGN's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

AMGN past revenue growth

How has AMGN's revenue growth performed historically?
Company
2.18%
Industry
12.36%
Market
154.86%
AMGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AMGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AMGN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AMGN earnings and revenue history

Current Revenue
$26.3B
Current Earnings
$6.8B
Current Profit Margin
26%
AMGN's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

AMGN Return on Equity

Current Company
199.7%
Current Industry
48.8%
Current Market
-8.3%
AMGN's Return on Equity (199.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AMGN announces earnings.

AMGN Return on Assets

Current Company
11.2%
Current Industry
11.3%
AMGN is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AMGN Return on Capital Employed

Current Company
18.34%
Current Industry
17.8%
AMGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AMGN vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AMGN$26.33B$12.41B$6.84B+2.73%+2.36%
SNY$42.46B$11.96B$6.71B+1.30%-7.60%
BMY$46.74B$18.03B$6.68B+17.84%+3.75%
GILD$27.14B$7.62B$3.33B-0.25%-21.33%
NVS$52.26B$21.05B$21.80B+1.06%+28.17%

AMGN earnings dates

Next earnings date
Jan 31, 2023

Amgen Earnings & Revenue FAQ

What were AMGN's earnings last quarter?

On Invalid Date, Amgen (NASDAQ: AMGN) reported Q3 2022 earnings per share (EPS) of $4.01, up 20.78% year over year. Total Amgen earnings for the quarter were $2.14 billion. In the same quarter last year, Amgen's earnings per share (EPS) was $3.32.

If you're new to stock investing, here's how to buy Amgen stock.

What was AMGN's earnings growth in the past year?

As of Q1 2023, Amgen's earnings has grown 28.15% year over year. This is 11.36 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 39.51%. Amgen's earnings in the past year totalled $6.84 billion.

What is AMGN's earnings date?

Amgen's earnings date is Invalid Date. Add AMGN to your watchlist to be reminded of AMGN's next earnings announcement.

What was AMGN's revenue last quarter?

On Invalid Date, Amgen (NASDAQ: AMGN) reported Q3 2022 revenue of $6.65 billion up 0.81% year over year. In the same quarter last year, Amgen's revenue was $6.71 billion.

What was AMGN's revenue growth in the past year?

As of Q1 2023, Amgen's revenue has grown 2.18% year over year. This is 10.18 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.36%. Amgen's revenue in the past year totalled $26.33 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.